The Canadian pharmaceutical industry, which includes branded and generic prescription drugs, as well as OTC products, is about C$11.5 billion, according to PMMI Business Intelligence’s new report “The Market for Packaging Machinery in Canada 2018.”
Canadian generics have gained share, due to large Canadian manufacturers such as Apotex and Pharmasciences’ focused efforts. Generics have consistently been relatively more expensive, thus boosting industry revenue.
The main engine for growth is increasing use of biologics. A second potential area for growth is the legalized cannabis industry. Demands for anti-counterfeiting features in packaging will also likely increase, due to the Drug Supply Chain Security Act (DSCSA).
Canadian pharma packaging is more functional than marketing driven, with the exception of OTC. Rigid plastic containers are most common, both for pills and liquids. Paperboard is used for folding cartons for secondary packaging and blister packs.
Download the FREE executive summary of this report, or, PMMI Members can download the entire report for free here.
Source: PMMI Business Intelligence, “The Market for Packaging Machinery in Canada 2018”
